Navigation Links
Simeprevir Administered Once Daily as Part of Combination Therapy Demonstrates Sustained Virologic Response in Treatment-Naive and Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Date:11/2/2013

f the other Janssen Pharmaceutical Companies and/or Johnson & Johnson.  Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; challenges to patents; impact of business combinations; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to governmental laws and regulations and domestic and foreign health care reforms; trends toward health care cost containment; and increased scrutiny of the health care industry by government agencies.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 30, 2012.  Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson.  None of the Janssen Pharmaceutical Companies nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)

Media Contact: Daniel De Schryver               
Mobile: +49 173 76 89 149

Media Contact: Craig Stoltz               
Mobile: +1 (215) 325-3612

Investor Contact: Stan Panasewicz                      
Off
'/>"/>

SOURCE Janssen R&D Ireland
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
2. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
3. U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
4. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
5. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
6. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
7. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
8. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
9. MCOs Shifting Control Over Office-Administered Products from Medical to Pharmacy Benefit, Particularly Affecting Rheumatoid Arthritis Therapies
10. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
11. Daiichi Sankyos Once-Daily Edoxaban Shows Comparable Efficacy and Superiority for the Principal Safety Endpoint Compared to Warfarin in a Phase 3 Study for the Treatment of Symptomatic VTE and Prevention of its Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... the addition of the "North American Active ... by Application (Surgical Wound, & Ulcer), by End-User ... 2019" report to their offering. ,     (Logo: ... market is estimated to grow at a CAGR ...
(Date:5/21/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced that on ... company,s vice president of operations, was granted an option to ... per share exercise price of $0.43, the closing trading price ... to Cardica, Inc.,s Inducement Plan, which was approved by the ... of the Nasdaq Global Market for equity grants to induce ...
(Date:5/21/2015)... CAMBRIDGE, England , May 21, ... zur Bekämpfung von Arzneimittelfälschungen - Zwecks ... eines Arzneimittelprüfdienstes wird auf EG-Mitgliedstaaten verwiesen, ... Pilotsysteme betrieben werden.  Wählen Sie ein ... Bei der Richtlinie zur Bekämpfung von ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... The U.S. Food and Drug Administration today issued new ... needle-free clinical devices to administer influenza vaccinations. Based on ... ) immediately discontinued use of such clinical devices at ... The Kroger family of pharmacies and The Little ...
... HAYWARD, Calif., Oct. 21, 2011 Intarcia ... a letter of intent with Quintiles , the world,s ... 3 program for Intarcia,s ITCA 650 (DUROS® subcutaneous continuous delivery ... GLP-1 therapy to better address the unmet needs of the ...
Cached Medicine Technology:Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 2Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 3Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 4
(Date:5/23/2015)... 2015 On May 16, the team at ... was a 5k mud obstacle run that raised funds for ... people worldwide, and the reason we participated was to support ... owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds ... The event was not only attended by eXtreme Bodyshaping staff, ...
(Date:5/23/2015)... A live auction will be held to ... centers and other medical facilities around the United States. ... radiology, surgery, anesthesia, exam and much more. , The ... May 28 starting at 9:00am CDT each day. The equipment ... Avenue, Melrose Park, IL 60160. Anyone can participate in ...
(Date:5/23/2015)... Aliso Viejo, CA (PRWEB) May 23, 2015 ... Prism from Pixel Film Studios. , It's as simple ... well as utilizing the included tool for full effect. ... were filmed on high-dynamic range 5k sensors making this the ... , The prismatic flares included in this package are movie ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... The American College of Traditional Chinese ... They will hold a webinar on the updates of ... on Classical Chinese Medicine. , Webinar – First Professional ... the Dean of Clinical Education, will lead this webinar ... Doctorate program. ACTCM is currently developing this degree program ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2
... September 20, 2011 Most parents recognize that the influence ... But, just how far do these influences reach? A study ... reports that adolescents are more likely to start drinking alcoholic ... The findings suggest that, in addition to well-established demographic ...
... Africa, women who are empowered to make household decisions tend ... study conducted by researchers at the Johns Hopkins Bloomberg School ... autonomy and the time since most recent sexual intercourse and ... activity. The full article will be published in the October ...
... selected a pediatric cancer survivor, Bella Rodriguez-Torres, as its 2011 ... award and $1,000 during the Awards Ceremony on Tuesday, October ... Miami Beach, Fla. , The Survivor Circle Award recognizes a ... devoted his or her time to helping others who are ...
... is all it could take to tell if you are ... of international scientists have discovered more than 10 types of ... a person who recently suffered a stroke or heart attack. ... collaboration led by Nanyang Technological University (NTU),s lead scientist, Assistant ...
... risk assessment calculator hosted at the World Health Organization ... ( http://www.shef.ac.uk/FRAX ), has now been released in version ... a desktop option, FRAX is becoming increasingly accessible to ... ,FRAX is now available for use without internet. ...
... is as effective as widely used antipsychotic drugs in managing ... side effects, a new study shows. The first major ... behavioural disturbances and social engagement in dementia patients found both ... researcher, Dr Lee-Fay Low, a Research Fellow in the School ...
Cached Medicine News:Health News:Extent of peer social networks influences onset of adolescent alcohol consumption 2Health News:Extent of peer social networks influences onset of adolescent alcohol consumption 3Health News:Increased responsibility could lead to decreased sexual activity among women 2Health News:Courageous 8-year-old honored with 2011 Survivor Circle Award 2Health News:Novel research set to pinpoint risk of heart attacks and strokes 2Health News:Novel research set to pinpoint risk of heart attacks and strokes 3Health News:FRAX calculator issued in version 3.4 2Health News:Humor as effective as medication in treating agitation in dementia 2
... can be useful in the treatment of ... normalizing blood sugar. Post cataract surgery - ... Accommodative esotropia - address residual near deviation. ... - add bifocals. Specialty - add correction ...
... quality. Set of 16 includes 1/2, 1, 2, 4, 6, ... 50 diopter plus Red Lens. Each measures 37mm square. 4449 ... ,These prisms are of superior quality. Set of 22 includes ... 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, ...
... the #1 product of choice by physicians ... years. Remote control handpiece to change power ... procedural time. Dual Microprocessors: one to control ... the second to terminate activation if a ...
... the most powerful isolated ESU on the market ... is the only ESU that allows the surgeon ... with a standard ES pencil. Excalibur Plus PC ... necessary voltage for smooth cutting through various impedance ...
Medicine Products: